Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil
S C Linn, C K van Kalken, O van Tellingen, et al.
Journal of Clinical Pharmacology
|
April 21, 2011
From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies
S L W Koolen, R A B van Waterschoot, O van Tellingen, et al.
Journal of Chromatography
|
May 5, 1993
Determination of intoplicine, a new antitumour drug, in human whole blood and plasma by normal-phase high-performance liquid chromatography with fluorescence detection
R van Gijn, H Rosing, W W ten Bokkel Huinink, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 1997
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
A Sparreboom, J van Asperen, U Mayer, et al.
Anti-Cancer Drugs
|
May 4, 2001
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel
M M Malingré, J H Beijnen, H Rosing, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
O van Tellingen, C J Punt, A Awada, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2001
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
M M Malingré, J H Beijnen, H Rosing, et al.
Anti-Cancer Drugs
|
November 21, 1998
Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer
V R Panday, W W ten Bokkel Huinink, H Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
Coadministration of oral cyclosporin A enables oral therapy with paclitaxel
J M Meerum Terwogt, M M Malingré, J H Beijnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2000
Phase I and pharmacokinetic study of oral paclitaxel
M M Malingré, J M Terwogt, J H Beijnen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridil
S C Linn, C K van Kalken, O van Tellingen, et al.
Journal of Clinical Pharmacology
|
April 21, 2011
From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies
S L W Koolen, R A B van Waterschoot, O van Tellingen, et al.
Journal of Chromatography
|
May 5, 1993
Determination of intoplicine, a new antitumour drug, in human whole blood and plasma by normal-phase high-performance liquid chromatography with fluorescence detection
R van Gijn, H Rosing, W W ten Bokkel Huinink, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 1997
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
A Sparreboom, J van Asperen, U Mayer, et al.
Anti-Cancer Drugs
|
May 4, 2001
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel
M M Malingré, J H Beijnen, H Rosing, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
O van Tellingen, C J Punt, A Awada, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2001
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A
M M Malingré, J H Beijnen, H Rosing, et al.
Anti-Cancer Drugs
|
November 21, 1998
Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer
V R Panday, W W ten Bokkel Huinink, H Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
Coadministration of oral cyclosporin A enables oral therapy with paclitaxel
J M Meerum Terwogt, M M Malingré, J H Beijnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2000
Phase I and pharmacokinetic study of oral paclitaxel
M M Malingré, J M Terwogt, J H Beijnen, et al.
Page
of 10